Genomma Lab Internacional, S.A.B. de C.V Key Executives

This section highlights Genomma Lab Internacional, S.A.B. de C.V's key executives, including their titles and compensation details.

Unlock Executive Information

Upgrade to access executive details

Upgrade Now

Find Contacts at Genomma Lab Internacional, S.A.B. de C.V

(Showing 0 of )

Unlock Team Information

Upgrade to access team member details

Upgrade Now

Genomma Lab Internacional, S.A.B. de C.V Earnings

This section highlights Genomma Lab Internacional, S.A.B. de C.V's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date: April 22, 2025
Time: Before Market
Est. EPS: $-
Status: Unconfirmed

Last Earnings Results

Date: February 26, 2025
EPS: $0.50
Est. EPS: $0.59
Revenue: $4.67B

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS

Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Healthcare Drug Manufacturers - Specialty & Generic

$24.82

Stock Price

$24.82B

Market Cap

-

Employees

Mexico City, DF

Location

Financial Statements

Access annual & quarterly financial statements for Genomma Lab Internacional, S.A.B. de C.V, including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $18.61B $16.47B $16.82B $15.49B $13.87B
Cost of Revenue $6.68B $6.38B $6.66B $5.92B $5.28B
Gross Profit $11.93B $10.08B $10.16B $9.56B $8.59B
Gross Profit Ratio 64.12% 61.20% 60.43% 61.70% 61.92%
Research and Development Expenses $- $- $- $- $-
General and Administrative Expenses $7.65B $6.84B $6.92B $6.57B $5.67B
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $7.65B $6.84B $6.92B $6.57B $5.67B
Other Expenses $301.33M $-14.68M $2.29M $63.44M $-153.09M
Operating Expenses $7.95B $6.82B $6.92B $6.57B $5.67B
Cost and Expenses $14.62B $13.21B $13.58B $12.49B $10.95B
Interest Income $106.11M $156.93M $118.05M $65.43M $31.40M
Interest Expense $887.80M $829.90M $525.64M $444.39M $461.11M
Depreciation and Amortization $359.59M $227.30M $227.12M $170.27M $158.99M
EBITDA $4.14B $2.82B $3.01B $2.84B $3.04B
EBITDA Ratio 22.24% 17.14% 20.23% 20.51% 21.89%
Operating Income $3.98B $3.26B $3.25B $3.05B $2.77B
Operating Income Ratio 21.40% 19.80% 19.29% 19.67% 19.96%
Total Other Income Expenses Net $-1.09B $-1.54B $-988.36M $-824.67M $-597.67M
Income Before Tax $2.89B $1.72B $2.26B $2.22B $2.24B
Income Before Tax Ratio 15.54% 10.45% 13.42% 14.35% 16.13%
Income Tax Expense $753.78M $635.67M $867.61M $914.01M $766.83M
Net Income $2.14B $1.08B $1.39B $1.31B $1.40B
Net Income Ratio 11.49% 6.59% 8.26% 8.44% 10.12%
EPS $2.26 $1.13 $1.40 $1.30 $1.39
EPS Diluted $2.26 $1.13 $1.40 $1.30 $1.39
Weighted Average Shares Outstanding 944.86M 957.34M 993.23M 1.01B 1.01B
Weighted Average Shares Outstanding Diluted 944.86M 957.34M 993.23M 1.01B 1.01B
SEC Filing Source Source Source Source Source


Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Revenue $4.67B $5.09B $4.65B $4.20B $3.53B $4.39B $4.37B $4.18B $4.13B $4.35B $4.32B $4.01B $4.09B $3.98B $3.87B $3.55B $3.47B $3.43B $3.64B $3.33B
Cost of Revenue $1.72B $1.82B $1.67B $1.46B $1.41B $1.65B $1.71B $1.61B $1.78B $1.66B $1.71B $1.50B $1.51B $1.53B $1.51B $1.37B $1.31B $1.24B $1.46B $1.27B
Gross Profit $2.94B $3.27B $2.98B $2.74B $2.11B $2.74B $2.66B $2.56B $2.35B $2.69B $2.61B $2.51B $2.58B $2.45B $2.35B $2.18B $2.16B $2.19B $2.18B $2.06B
Gross Profit Ratio 63.05% 64.30% 64.00% 65.30% 59.90% 62.40% 61.00% 61.40% 56.90% 61.80% 60.40% 62.60% 63.00% 61.60% 60.80% 61.50% 62.17% 63.88% 59.91% 61.83%
Research and Development Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
General and Administrative Expenses $1.84B $2.08B $1.92B $1.81B $1.50B $1.80B $1.80B $1.74B $1.64B $1.81B $1.72B $1.75B $1.86B $1.68B $1.57B $1.45B $1.43B $1.42B $1.43B $1.38B
Selling and Marketing Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Selling General and Administrative Expenses $1.84B $2.08B $1.92B $1.81B $1.50B $1.80B $1.80B $1.74B $1.64B $1.81B $1.72B $1.75B $1.86B $1.68B $1.57B $1.45B $1.43B $1.42B $1.43B $1.38B
Other Expenses $87.11M $61.61M $76.07M $1.80M $- $- $- $48.50M $- $- $- $61.26M $- $- $- $-1.08M $- $- $- $1.25M
Operating Expenses $1.93B $2.14B $1.99B $1.88B $1.42B $1.86B $1.79B $1.81B $1.58B $1.83B $1.77B $1.80B $1.80B $1.67B $1.61B $1.49B $1.32B $1.46B $1.46B $1.42B
Cost and Expenses $3.65B $3.96B $3.67B $3.34B $2.83B $3.51B $3.50B $3.42B $3.37B $3.49B $3.48B $3.30B $3.31B $3.20B $3.12B $2.86B $2.64B $2.70B $2.92B $2.70B
Interest Income $36.80M $25.35M $9.01M $34.96M $-41.33M $100.37M $63.00M $34.88M $35.45M $42.32M $30.54M $9.74M $9.62M $51.04M $1.35M $3.42M $4.34M $14.65M $6.91M $5.50M
Interest Expense $248.37M $230.25M $208.56M $200.62M $218.30M $208.16M $221.44M $182.00M $162.21M $136.96M $126.31M $100.16M $99.42M $172.62M $83.92M $88.43M $96.98M $121.25M $113.58M $129.30M
Depreciation and Amortization $121.19M $88.53M $59.84M $90.02M $37.09M $60.36M $61.19M $68.67M $56.22M $57.84M $56.92M $56.15M $57.20M $37.47M $36.28M $39.31M $40.62M $38.83M $40.87M $38.67M
EBITDA $968.71M $1.25B $1.13B $807.64M $361.53M $816.86M $857.48M $741.93M $785.40M $932.90M $796.85M $655.11M $669.46M $875.55M $666.89M $709.32M $619.11M $771.30M $763.55M $747.67M
EBITDA Ratio 20.76% 24.57% 25.87% 19.90% 14.71% 20.89% 19.17% 18.32% 19.63% 21.45% 18.43% 19.61% 19.10% 21.98% 19.20% 21.90% 19.23% 22.50% 21.00% 25.22%
Operating Income $1.01B $1.13B $983.28M $857.25M $699.08M $885.77M $871.07M $803.80M $770.72M $859.43M $839.82M $775.21M $834.34M $783.45M $741.99M $686.77M $680.93M $731.66M $714.86M $640.56M
Operating Income Ratio 21.71% 22.17% 21.14% 20.42% 19.83% 20.16% 19.93% 19.24% 18.65% 19.76% 19.42% 19.31% 20.40% 19.67% 19.20% 19.36% 19.62% 21.34% 19.66% 19.21%
Total Other Income Expenses Net $-413.97M $-196.56M $-140.61M $-340.25M $-592.95M $-337.42M $-296.21M $-312.55M $-203.75M $-245.26M $-226.20M $-276.40M $-321.50M $-202.69M $-195.29M $-105.19M $-199.41M $-164.78M $-105.75M $-60.85M
Income Before Tax $599.15M $932.26M $842.67M $517.00M $106.14M $548.35M $574.85M $491.25M $566.97M $614.18M $613.62M $498.80M $512.84M $580.76M $546.70M $581.58M $481.52M $566.89M $609.10M $579.71M
Income Before Tax Ratio 12.84% 18.31% 18.12% 12.32% 3.01% 12.48% 13.15% 11.76% 13.72% 14.12% 14.19% 12.42% 12.54% 14.58% 14.14% 16.39% 13.87% 16.54% 16.75% 17.38%
Income Tax Expense $125.66M $272.20M $211.03M $144.90M $167.29M $177.68M $157.45M $133.25M $259.22M $214.90M $208.87M $159.62M $296.79M $187.56M $167.49M $262.17M $154.72M $157.75M $248.29M $206.07M
Net Income $473.49M $660.06M $631.64M $372.11M $-61.16M $370.67M $417.40M $358.00M $307.75M $399.28M $404.75M $339.19M $216.04M $393.20M $379.20M $319.42M $326.79M $409.14M $360.82M $373.63M
Net Income Ratio 10.15% 12.96% 13.58% 8.87% -1.73% 8.44% 9.55% 8.57% 7.45% 9.18% 9.36% 8.45% 5.28% 9.87% 9.81% 9.00% 9.41% 11.94% 9.92% 11.20%
EPS $0.50 $0.66 $0.67 $0.36 $-0.06 $0.38 $0.43 $0.37 $0.32 $0.41 $0.40 $0.34 $0.00 $0.39 $0.37 $0.31 $0.00 $0.40 $0.35 $0.37
EPS Diluted $0.50 $0.66 $0.67 $0.36 $-0.06 $0.38 $0.43 $0.37 $0.32 $0.41 $0.40 $0.34 $0.00 $0.39 $0.37 $0.31 $0.00 $0.40 $0.35 $0.37
Weighted Average Shares Outstanding 944.86M 1.00B 942.75M 1.03B 952.70M 948.05M 964.51M 964.51M 964.51M 964.51M - 1.00B - 1.00B - 1.02B - 1.02B - 1.02B
Weighted Average Shares Outstanding Diluted 944.86M 1.00B 942.75M 1.03B 952.70M 948.05M 964.51M 964.51M 964.51M 964.51M - 1.00B - 1.00B - 1.02B - 1.02B - 1.02B
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents $2.38B $1.47B $1.50B $1.22B $2.05B
Short Term Investments $- $183.23M $205.93M $- $-
Cash and Short Term Investments $2.38B $1.66B $1.50B $1.22B $2.05B
Net Receivables $- $- $- $- $-
Inventory $2.18B $1.91B $2.40B $2.20B $2.05B
Other Current Assets $7.84B $7.10B $7.42B $8.21B $8.05B
Total Current Assets $12.40B $10.67B $11.31B $11.52B $12.04B
Property Plant Equipment Net $3.56B $3.41B $3.59B $3.37B $2.85B
Goodwill $- $- $- $- $-
Intangible Assets $5.93B $4.96B $5.15B $5.17B $4.91B
Goodwill and Intangible Assets $5.93B $4.96B $5.15B $5.17B $4.91B
Long Term Investments $- $545.92M $787.75M $765.00M $1.70B
Tax Assets $1.65B $611.61M $593.93M $500.76M $540.11M
Other Non-Current Assets $538.00M $534.21M $168.90M $220.88M $93.52M
Total Non-Current Assets $11.68B $10.07B $10.29B $10.02B $10.10B
Other Assets $- $- $- $- $-
Total Assets $24.08B $20.74B $21.61B $21.54B $22.13B
Account Payables $1.74B $1.84B $1.79B $1.44B $1.64B
Short Term Debt $- $2.01B $4.85B $2.11B $2.01B
Tax Payables $367.69M $880.93M $1.04B $1.25B $275.79M
Deferred Revenue $- $- $- $- $-
Other Current Liabilities $4.65B $1.90B $1.68B $1.78B $2.69B
Total Current Liabilities $6.75B $6.62B $9.36B $6.57B $6.61B
Long Term Debt $5.06B $4.23B $1.59B $3.86B $4.47B
Deferred Revenue Non-Current $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $326.36M $392.73M $554.70M $551.64M
Other Non-Current Liabilities $676.04M $114.50M $115.08M $489.14M $858.28M
Total Non-Current Liabilities $5.74B $4.67B $2.10B $4.90B $5.88B
Other Liabilities $- $- $- $- $-
Total Liabilities $12.49B $11.30B $11.45B $11.47B $12.50B
Preferred Stock $- $- $- $- $-
Common Stock $1.83B $1.86B $1.91B $1.91B $1.91B
Retained Earnings $12.21B $10.83B $10.05B $9.42B $8.88B
Accumulated Other Comprehensive Income Loss $- $- $- $- $-
Other Total Stockholders Equity $-2.45B $-3.25B $-2.13B $-1.26B $-1.95B
Total Stockholders Equity $11.59B $9.44B $10.15B $10.07B $9.63B
Total Equity $11.59B $9.44B $10.15B $10.07B $9.63B
Total Liabilities and Stockholders Equity $24.08B $20.74B $21.61B $21.54B $22.13B
Minority Interest $- $- $- $- $-
Total Liabilities and Total Equity $24.08B $20.74B $21.61B $21.54B $22.13B
Total Investments $- $729.15M $787.75M $765.00M $1.70B
Total Debt $5.06B $6.24B $6.44B $5.96B $6.48B
Net Debt $2.69B $4.77B $4.94B $4.74B $4.43B


Balance Sheet Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Cash and Cash Equivalents $2.38B $1.83B $1.23B $1.14B $1.47B $1.76B $1.37B $1.25B $1.50B $1.09B $1.30B $1.55B $1.22B $1.76B $1.41B $1.82B $2.05B $1.57B $1.19B $1.35B
Short Term Investments $- $- $- $- $183.23M $- $- $963.70M $205.93M $- $- $- $- $- $- $- $- $- $- $-
Cash and Short Term Investments $2.38B $1.83B $1.23B $1.14B $1.66B $1.76B $1.37B $1.25B $1.50B $1.09B $1.30B $1.55B $1.22B $1.76B $1.41B $1.82B $2.05B $1.57B $1.19B $1.35B
Net Receivables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Inventory $2.18B $2.22B $2.09B $1.95B $1.91B $2.31B $2.22B $2.34B $2.40B $2.86B $2.52B $2.42B $2.20B $2.44B $2.51B $2.34B $2.05B $2.27B $2.19B $2.07B
Other Current Assets $7.84B $8.15B $8.16B $7.97B $7.10B $7.87B $7.94B $7.90B $7.42B $7.63B $7.99B $8.13B $8.21B $8.49B $8.46B $8.17B $8.05B $8.04B $7.94B $7.86B
Total Current Assets $12.40B $12.19B $11.48B $11.07B $10.67B $11.94B $11.53B $11.49B $11.31B $11.59B $11.80B $12.11B $11.52B $12.69B $12.38B $12.33B $12.04B $11.88B $11.32B $11.28B
Property Plant Equipment Net $3.56B $3.50B $3.50B $3.46B $3.41B $3.44B $3.45B $3.65B $3.59B $3.50B $3.47B $3.42B $3.37B $3.25B $3.08B $3.01B $2.85B $2.56B $2.43B $2.32B
Goodwill $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Intangible Assets $5.93B $5.87B $5.21B $5.09B $4.96B $5.11B $5.12B $4.98B $5.15B $5.03B $5.02B $4.99B $5.17B $4.95B $4.90B $4.88B $4.91B $4.90B $4.92B $4.94B
Goodwill and Intangible Assets $5.93B $5.87B $5.21B $5.09B $4.96B $5.11B $5.12B $4.98B $5.15B $5.03B $5.02B $4.99B $5.17B $4.95B $4.90B $4.88B $4.91B $4.90B $4.92B $4.94B
Long Term Investments $- $- $- $- $545.92M $- $- $-200.69M $787.75M $- $- $- $765.00M $- $- $- $1.70B $- $- $-
Tax Assets $1.65B $1.40B $1.24B $1.02B $611.61M $864.08M $824.90M $963.70M $593.93M $995.46M $1.02B $922.13M $500.76M $601.67M $774.20M $707.15M $540.11M $778.25M $772.93M $754.78M
Other Non-Current Assets $538.00M $538.00M $550.00M $669.16M $534.21M $719.88M $759.66M $963.70M $168.90M $717.13M $697.34M $724.71M $220.88M $1.74B $1.74B $1.72B $93.52M $1.66B $1.65B $1.61B
Total Non-Current Assets $11.68B $11.31B $10.50B $10.25B $10.07B $10.14B $10.15B $10.35B $10.29B $10.24B $10.21B $10.06B $10.02B $10.54B $10.49B $10.32B $10.10B $9.90B $9.78B $9.63B
Other Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $24.08B $23.51B $21.98B $21.31B $20.74B $22.08B $21.68B $21.84B $21.61B $21.83B $22.01B $22.16B $21.54B $23.23B $22.87B $22.65B $22.13B $21.78B $21.10B $20.91B
Account Payables $1.74B $1.89B $1.77B $1.91B $1.84B $1.99B $1.88B $1.60B $1.79B $2.10B $1.98B $1.80B $1.44B $1.78B $2.04B $1.97B $1.64B $1.75B $1.86B $1.71B
Short Term Debt $- $- $1.53B $2.11B $2.01B $2.25B $2.54B $4.72B $4.85B $4.14B $1.86B $1.74B $2.11B $2.36B $2.06B $2.08B $2.01B $1.87B $4.48B $1.97B
Tax Payables $367.69M $185.61M $206.86M $238.81M $880.93M $328.59M $364.90M $441.75M $1.04B $381.37M $304.36M $490.06M $1.25B $386.07M $258.67M $353.28M $275.79M $250.61M $234.13M $331.15M
Deferred Revenue $- $- $206.86M $238.81M $- $328.59M $364.90M $441.75M $- $381.37M $304.36M $490.06M $- $386.07M $258.67M $353.28M $- $250.61M $234.13M $331.15M
Other Current Liabilities $4.65B $4.64B $2.64B $2.63B $1.90B $2.25B $2.20B $2.74B $1.68B $2.70B $2.92B $2.95B $1.78B $2.62B $2.73B $2.61B $2.69B $2.77B $2.65B $2.60B
Total Current Liabilities $6.75B $6.72B $6.14B $6.89B $6.62B $6.81B $6.98B $9.50B $9.36B $9.31B $7.06B $6.97B $6.57B $7.15B $7.10B $7.02B $6.61B $6.65B $9.23B $6.61B
Long Term Debt $5.06B $5.27B $4.85B $4.12B $4.23B $4.11B $3.73B $1.40B $1.59B $970.86M $3.59B $3.74B $3.86B $3.97B $4.11B $4.30B $4.47B $4.63B $1.72B $4.26B
Deferred Revenue Non-Current $- $- $- $- $- $- $- $-505.14M $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $326.36M $- $- $535.72M $392.73M $605.78M $571.90M $658.77M $554.70M $716.53M $728.07M $670.29M $551.64M $379.10M $415.76M $543.82M
Other Non-Current Liabilities $676.04M $365.25M $417.57M $533.35M $114.50M $532.65M $508.13M $30.58M $115.08M $15.67M $15.67M $408.24M $489.14M $800.00M $800.00M $800.00M $858.28M $800.00M $800.00M $800.00M
Total Non-Current Liabilities $5.74B $5.64B $5.26B $4.65B $4.67B $4.65B $4.24B $1.97B $2.10B $1.59B $4.18B $4.81B $4.90B $5.49B $5.64B $5.77B $5.88B $5.80B $2.94B $5.61B
Other Liabilities $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $12.49B $12.36B $11.41B $11.54B $11.30B $11.46B $11.22B $11.46B $11.45B $10.91B $11.24B $11.78B $11.47B $12.64B $12.73B $12.79B $12.50B $12.45B $12.16B $12.22B
Preferred Stock $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock $1.83B $1.86B $1.86B $1.86B $1.86B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B $1.91B
Retained Earnings $12.21B $11.97B $11.51B $11.01B $10.83B $10.58B $10.48B $10.32B $10.05B $10.41B $10.16B $9.77B $9.42B $9.96B $9.46B $9.11B $8.88B $8.74B $8.27B $7.97B
Accumulated Other Comprehensive Income Loss $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Total Stockholders Equity $-2.45B $-2.68B $-2.80B $-3.10B $-3.25B $-1.88B $-1.93B $-1.85B $-2.13B $-1.40B $-1.30B $-1.30B $-1.26B $-1.27B $-1.24B $-1.17B $-1.95B $-1.32B $-1.24B $-1.20B
Total Stockholders Equity $11.59B $11.15B $10.58B $9.77B $9.44B $10.62B $10.46B $10.38B $10.15B $10.92B $10.78B $10.38B $10.07B $10.59B $10.13B $9.86B $9.63B $9.33B $8.94B $8.68B
Total Equity $11.59B $11.15B $10.58B $9.77B $9.44B $10.62B $10.46B $10.38B $10.15B $10.92B $10.78B $10.38B $10.07B $10.59B $10.13B $9.86B $9.63B $9.33B $8.94B $8.68B
Total Liabilities and Stockholders Equity $24.08B $23.51B $21.98B $21.31B $20.74B $22.08B $21.68B $21.84B $21.61B $21.83B $22.01B $22.16B $21.54B $23.23B $22.87B $22.65B $22.13B $21.78B $21.10B $20.91B
Minority Interest $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities and Total Equity $24.08B $23.51B $21.98B $21.31B $20.74B $22.08B $21.68B $21.84B $21.61B $21.83B $22.01B $22.16B $21.54B $23.23B $22.87B $22.65B $22.13B $21.78B $21.10B $20.91B
Total Investments $- $- $- $669.16M $729.15M $719.88M $759.66M $763.01M $787.75M $717.13M $697.34M $724.71M $765.00M $1.74B $1.74B $1.72B $1.70B $1.66B $1.65B $1.61B
Total Debt $5.06B $5.27B $6.37B $6.23B $6.24B $4.11B $6.27B $6.12B $6.44B $5.11B $5.45B $5.48B $5.96B $6.34B $6.17B $6.38B $6.48B $6.50B $6.20B $6.23B
Net Debt $2.69B $3.44B $5.14B $5.09B $4.77B $2.35B $4.90B $4.88B $4.94B $4.02B $4.15B $3.93B $4.74B $4.58B $4.77B $4.56B $4.43B $4.93B $5.01B $4.89B

Annual Cash Flow

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $2.14B $1.08B $1.39B $1.31B $1.47B
Depreciation and Amortization $359.59M $227.30M $227.12M $170.27M $158.99M
Deferred Income Tax $- $- $- $- $-
Stock Based Compensation $- $- $- $- $-
Change in Working Capital $-529.33M $458.66M $-273.61M $-811.40M $-434.17M
Accounts Receivables $-592.72M $66.34M $- $- $-
Inventory $-242.70M $-164.18M $-434.59M $-227.60M $-227.55M
Accounts Payables $- $- $- $- $-
Other Working Capital $306.09M $556.50M $160.99M $-583.80M $-206.62M
Other Non Cash Items $1.05B $476.14M $712.07M $801.62M $519.33M
Net Cash Provided by Operating Activities $3.02B $2.25B $2.05B $1.47B $1.71B
Investments in Property Plant and Equipment $-227.52M $- $-19.47M $-206.58M $-7.78M
Acquisitions Net $- $- $- $- $-
Purchases of Investments $-1.57M $-144.90M $-205.93M $- $-
Sales Maturities of Investments $- $- $- $- $-
Other Investing Activities $-584.13M $-157.31M $-262.82M $-559.04M $-655.87M
Net Cash Used for Investing Activities $-813.23M $-302.21M $-282.30M $-765.62M $-663.65M
Debt Repayment $124.62M $-89.07M $490.99M $-522.44M $432.45M
Common Stock Issued $11.11M $1.74B $471.15M $76.90M $283.33M
Common Stock Repurchased $- $-1.90B $-994.92M $-155.81M $-15.44M
Dividends Paid $-778.82M $-580.70M $-777.66M $-391.76M $-
Other Financing Activities $-947.95M $-844.78M $-551.95M $-476.14M $-510.50M
Net Cash Used Provided by Financing Activities $-1.59B $-1.68B $-1.36B $-1.47B $189.85M
Effect of Forex Changes on Cash $90.82M $-77.59M $-171.06M $-72.54M $-59.79M
Net Change in Cash $684.34M $190.39M $239.04M $-839.04M $1.18B
Cash at End of Period $2.36B $1.49B $1.50B $1.26B $2.10B
Cash at Beginning of Period $1.67B $1.30B $1.26B $2.10B $922.94M
Operating Cash Flow $3.02B $2.25B $2.05B $1.47B $1.71B
Capital Expenditure $-227.52M $-88.90M $-19.47M $-206.58M $-7.78M
Free Cash Flow $2.79B $2.16B $2.04B $1.26B $1.71B

Cash Flow Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Net Income $473.49M $660.06M $631.64M $372.11M $-61.16M $370.67M $417.40M $358.00M $190.20M $399.28M $404.75M $394.98M $216.04M $393.20M $379.20M $319.42M $326.79M $409.14M $360.82M $373.63M
Depreciation and Amortization $121.19M $88.53M $59.84M $90.02M $37.09M $60.36M $61.19M $68.67M $56.22M $57.84M $56.92M $56.15M $57.20M $37.47M $36.28M $39.31M $40.62M $38.83M $40.87M $38.67M
Deferred Income Tax $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Stock Based Compensation $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Change in Working Capital $469.06M $490.29M $-677.73M $-810.96M $524.99M $161.86M $-39.97M $-188.22M $-134.38M $-223.84M $-248.81M $333.41M $27.07M $-178.43M $-352.98M $-307.06M $313.43M $-317.60M $-321.68M $-108.32M
Accounts Receivables $252.62M $251.44M $-68.43M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Inventory $39.20M $-67.20M $-60.03M $-154.68M $194.40M $-201.49M $-34.48M $-122.62M $226.57M $-415.45M $15.38M $-261.09M $218.99M $64.70M $-218.00M $-293.29M $371.66M $-291.58M $-106.17M $-201.46M
Accounts Payables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Working Capital $177.25M $306.05M $-549.27M $- $- $363.35M $-5.49M $-65.60M $-360.95M $191.62M $-264.19M $594.50M $-191.92M $-243.13M $-134.97M $-13.77M $-58.23M $-26.02M $-215.51M $93.14M
Other Non Cash Items $208.20M $224.53M $245.04M $268.77M $314.98M $68.90M $9.09M $79.58M $225.58M $172.41M $62.88M $251.20M $401.96M $303.06M $-19.01M $115.60M $48.02M $212.77M $-3.09M $261.63M
Net Cash Provided by Operating Activities $1.27B $1.46B $412.08M $-126.45M $819.49M $661.79M $447.71M $318.03M $337.62M $405.69M $275.74M $1.04B $702.28M $555.31M $43.49M $167.27M $728.86M $343.13M $76.92M $565.61M
Investments in Property Plant and Equipment $-124.29M $-41.17M $-16.10M $-45.96M $- $-50.49M $-45.60M $-83.14M $- $-96.97M $-73.22M $-88.25M $- $-153.92M $-143.91M $-195.62M $- $-165.83M $-167.89M $-158.37M
Acquisitions Net $- $- $- $- $- $- $- $391.00K $- $- $- $270.00K $- $- $- $- $- $- $- $-
Purchases of Investments $-1.80M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Sales Maturities of Investments $- $1.97M $7.09M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Investing Activities $-714.00K $-556.13M $-58.67M $-25.57M $- $91.92M $66.44M $34.87M $- $85.23M $28.54M $9.76M $- $32.56M $-1.08M $3.40M $- $-246.00K $31.70M $22.06M
Net Cash Used for Investing Activities $-126.81M $-595.34M $-55.29M $-35.78M $-316.60M $41.42M $20.84M $-47.88M $-147.67M $-11.74M $-44.68M $-78.21M $-307.05M $-121.36M $-144.99M $-192.22M $-225.08M $-166.07M $-136.20M $-136.31M
Debt Repayment $-159.55M $132.00M $77.33M $74.84M $-179.76M $117.19M $197.10M $-223.60M $1.29B $-340.24M $33.04M $-494.12M $-382.85M $121.01M $-178.54M $-82.06M $-72.45M $321.82M $35.40M $147.69M
Common Stock Issued $- $- $68.45M $- $- $376.89M $336.64M $- $- $145.19M $178.63M $- $- $- $- $- $- $- $4.37M $4.37M
Common Stock Repurchased $-15.79M $-671.00K $- $-40.88M $-1.12B $-350.30M $-403.35M $-31.52M $- $-226.81M $-117.83M $- $-53.18M $-36.78M $-38.37M $-27.48M $-7.68M $-3.80M $-643.00K $-3.32M
Dividends Paid $-183.15M $-195.67M $-208.19M $-191.81M $- $-193.67M $-194.48M $- $- $- $-392.58M $- $- $- $- $- $- $- $- $-
Other Financing Activities $-260.56M $-248.97M $-238.38M $-200.04M $-408.11M $-212.14M $-227.67M $-189.41M $-1.01B $-143.87M $-130.85M $-151.03M $-494.60M $-180.99M $-95.05M $-97.26M $-111.76M $-118.94M $-138.75M $-141.05M
Net Cash Used Provided by Financing Activities $-619.04M $-313.32M $-300.79M $-357.89M $-678.52M $-262.02M $-291.75M $-444.53M $278.08M $-565.74M $-429.59M $-645.15M $-853.72M $-96.76M $-311.96M $-206.80M $87.07M $199.08M $-104.00M $7.69M
Effect of Forex Changes on Cash $23.89M $41.01M $35.23M $-9.31M $105.94M $-46.84M $-56.23M $-80.45M $-67.79M $-34.27M $-55.64M $-13.36M $-31.90M $9.03M $-1.82M $-47.84M $-54.62M $-18.02M $2.70M $10.15M
Net Change in Cash $535.91M $595.77M $74.94M $-552.65M $-252.36M $371.09M $132.99M $-273.81M $456.14M $-251.66M $-55.68M $276.44M $-445.93M $301.77M $-459.74M $-44.46M $559.51M $334.84M $-183.85M $423.87M
Cash at End of Period $2.37B $1.83B $1.22B $1.12B $1.49B $1.74B $1.38B $1.23B $1.50B $1.05B $1.24B $1.53B $1.26B $1.71B $1.36B $1.78B $2.10B $1.54B $1.19B $1.35B
Cash at Beginning of Period $1.83B $1.23B $1.14B $1.67B $1.74B $1.37B $1.25B $1.50B $1.05B $1.30B $1.30B $1.25B $1.71B $1.41B $1.82B $1.82B $1.54B $1.21B $1.37B $922.95M
Operating Cash Flow $1.27B $1.46B $412.08M $-126.45M $819.49M $661.79M $447.71M $318.03M $337.62M $405.69M $275.74M $1.04B $702.28M $555.31M $43.49M $167.27M $728.86M $343.13M $76.92M $565.61M
Capital Expenditure $-124.29M $-41.17M $-16.10M $-45.96M $- $-50.49M $-45.60M $-83.14M $- $-96.97M $-73.22M $-88.25M $- $-153.92M $-143.91M $-195.62M $- $-165.83M $-167.89M $-158.37M
Free Cash Flow $1.15B $1.42B $395.98M $-172.41M $819.49M $611.29M $402.11M $234.89M $337.62M $308.72M $202.53M $947.50M $702.28M $401.39M $-100.41M $-28.35M $728.86M $177.31M $-90.97M $407.24M

Genomma Lab Internacional, S.A.B. de C.V Dividends

Explore Genomma Lab Internacional, S.A.B. de C.V's dividend history, including dividend yield, payout ratio, and historical payments.

Dividend Yield

3.25%

Dividend Payout Ratio

36.44%

Dividend Paid & Capex Coverage Ratio

3.00x

Genomma Lab Internacional, S.A.B. de C.V Dividend History

Dividend Adjusted Dividend Date Record Date Payment Date Declaration Date
$0.2 $0.2 March 13, 2025
$0.2 $0.2 December 17, 2024
$0.2 $0.2 September 13, 2024
$0.2 $0.2 June 20, 2024
$0.19608 $0.19608 March 21, 2024
$0.19608 $0.19608 December 22, 2023
$0.19608 $0.19608 September 28, 2023
$0.19608 $0.19608 June 05, 2023
$0.38168 $0.38168 November 09, 2022
$0.38168 $0.38168 June 06, 2022
$0.38168 $0.38168 December 08, 2021
$0.76336 $0.76336 December 01, 2021

See full dividend history

Genomma Lab Internacional, S.A.B. de C.V News

Read the latest news about Genomma Lab Internacional, S.A.B. de C.V, including recent articles, headlines, and updates.

Similar Companies

A
Alfa, S. A. B. de C. V.

ALFAA.MX

Price: $16.80

Market Cap: $93.38B

View Details
G
Grupo Financiero Banorte, S.A.B. de C.V.

GFNORTEO.MX

Price: $150.98

Market Cap: $424.73B

View Details
G
Grupo México, S.A.B. de C.V.

GMEXICOB.MX

Price: $105.35

Market Cap: $820.15B

View Details
G
Gruma, S.A.B. de C.V.

GRUMAB.MX

Price: $365.37

Market Cap: $131.22B

View Details
K
Kimberly-Clark de México, S. A. B. de C. V.

KIMBERA.MX

Price: $32.57

Market Cap: $97.14B

View Details

Related Metrics

Explore detailed financial metrics and analysis for LABB.MX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio